A New Charge Reversal PCL-Block-Polyhistidine Nanoprticles for Nuclear Targeting Drug Delivery

Wednesday, November 10, 2010: 2:30 PM
151 A/B Room (Salt Palace Convention Center)
Erlei Jin Sr.1, Bo Zhang2, Jianbin Tang3, Maohong Fan4, Huadong Tang4, Maciej Radosz2, Edward A. Van Kirk5, William J. Murdoch5 and Youqing Shen3, (1)Chemical & Petroleum Engineering, University of Wyoming, Laramie, WY, (2)University of Wyoming, Laramie, WY, (3)Department of Chemical and Biochemical Engineering, Zhejiang University, Hangzhou, China, (4)Department of Chemical and Petroleum Engineering, University of Wyoming, Laramie, WY, (5)Department of Animal Science, University of Wyoming, Laramie, WY

Poly (L-histidine) (polyhis) has an endosomal membrane disruption activity due to its imidazole groups. It would be useful for cytosolic delivery of anticancer drug. However, its low aqueous solubility limits its application. We amidized its imidazole groups and thus substantially enhanced its water solubility. Its block copolymer with PCL could form nanoparticles with a size of around 130 nm. The nanoparticles are negatively charged at pH 7.4 but become positively charged at pH 5.0 due to the hydrolysis of the amides. The nanoparticles can go into nuclei within five hours for effective nuclear drug delivery. CPT and DOX loaded in the nanopartricles had higher cytotoxicity than the free drug.

Extended Abstract: File Not Uploaded
See more of this Session: Nanomedicine and Drug Delivery II
See more of this Group/Topical: Topical F: Nanotechnology in Medicine